Randox’s Post

The fourth(!) season of Superbugs and You is underway! The third episode, "Finding a Second Wind: Cystic Fibrosis," dropped this morning and features extraordinary insights from Ella Balasa, Dr Helen Boucher, and Mary Booth Dwight. I found this quote from Ella Balasa really thought-provoking, especially in terms of how we communicate about antimicrobial resistance (AMR): "I also think that it's so important to ground the problem in a relatable context. A lot of people think, 'Oh, yeah, AMR might affect this person that has CF and uses antibiotics all the time,' or 'Oh, this person that had tuberculosis, that's not something that I'll ever have to deal with,' but really, how common skin infections can be, or within the hospital setting too, getting an infection at a surgical site. It really can happen more often than one thinks, and so I think making AMR more relatable to the everyday average person, making sure that they understand the reality of what it can be...I think that's an area where I see one of the broadest impacts in how we can help to educate the public and help them understand." Huge shoutout to Elise Holmes, Dr Marnie Peterson, PharmD PhD, and Diane Flayhart for the massive amount of work they do to make this podcast series a reality! https://lnkd.in/gYphDNZH

🩸 Every hour counts in the fight against sepsis! Traditional methods are slow, but Bruker • Microbiology & Infection Diagnostics rapid solutions can delivers results in 15-20 mins, helping save lives. Learn more about their key Sepsityper solutions: https://lnkd.in/dbK94n5W   Make sure to follow the Practical Patient Care page and remember to subscribe for our weekly newsletter to stay updated on key topics such as... #diagnostics , #woundcare, #infectionprevention , and #criticalcare. #practicalpatientcare #ppc  ##sepsis #WorldSepsisDay #healthcareinnovation

Join us for live webinar on September 20th to learn about the clinical applications of PCT!

Every hour correct treatment is delayed, survival drops. Sepsis doesn’t wait, and neither should the diagnosis! We understand that you might face some hurdles in the battle against this life-threatening condition. 🩸 Speed & Accuracy: Traditional methods take way too long to identify. 🩸 Detecting the pathogens which are the causative agent of sepsis can be challenging. We know that when it comes to sepsis, every minute counts. Our cost-effective and accurate solution delivers the identification result in just 15-20 minutes from Positive Blood Culture, with hands-on-time under 10 minutes. Let’s save lives together. Get informed about our Sepsityper solutions: https://lnkd.in/dbK94n5W #sepsis #WorldSepsisDay #BrukerMID #MALDIBiotyper #GOTsirius #microbiology #bloodstreaminfection

Improve patient management by identifying rare and fastidious pathogens & take advantage of MMDx in clinical practice: https://lnkd.in/evriyzcR

🔬 Tackling STIs just got easier! Our infographic details the latest advancements in STI diagnosis and management. Get the inside scoop on effective methods for detecting and treating common STIs, plus insights into the pathogens responsible. 👩🔬 Developed with insights from Thermo Fisher Scientific, this valuable resource is perfect for healthcare professionals looking to enhance their diagnostic skills and provide better care. Why is this important for you? Staying updated with the most current practices helps ensure your patients receive the best possible outcomes. 👉 Check it out now: https://lnkd.in/gc62uw82 #ClinicalExcellence #STIManagement #HealthcareInnovation

Check our latest paper on nanosystems for sepsis.

Improve patient management by identifying rare and fastidious pathogens & take advantage of MMDx in clinical practice: https://lnkd.in/evriyzcR

Improve Patient Management By Identifying Rare And Fastidious Pathogens & Take Advantage of MMDx in Clinical Practice: https://lnkd.in/evriyzcR

It was a pleasure to discuss the value of biomarkers in the treatment of sepsis with MDR bacteria together with the two excellence speakers rita murri and Marc Leone. It became clear, that biomarkers alone are not sufficient to decide for or against the start of antibiotics. But they can help to shorten the treatment. The principles of antibiotic stewardship and shorter is better also apply to most MDR infections. Thanks to the European Sepsis alliance for hosting this insightful webinar.